Ученые нашли новую мишень для лечения экземы, изучив специфические волоски, вызывающие зуд

That Tissue Trick That Makes Your Peach Fuzz Itch Just Led to a Target for Eczema Drugs Roll the corner of a tissue into a fine point and drag it lightly across the fine hairs around your lips. Not the coarse, dark ones. The pale, short, barely visible fuzz. If you catch one at the right angle, you will want to scratch. The psychologist Edward Titchener described this sensation in healthy volunteers in 1909, and the field largely left it alone for a century. A team at the University of Michigan has now identified the specific hairs and the specific nerve cells responsible, and in doing so has handed itch researchers something they have been short of: a target for the kind of itch that current medications do almost nothing for. A Class of Hair Nobody Had Cataloged Working in mice, the team led by Bo Duan, an associate professor in the Department of Molecular, Cellular, and Developmental Biology, identified a previously unrecognized class of hairs they call vellus-like hairs, concentrated behind the ears and on the hindpaws. These correspond to the fine, short, lightly colored vellus hairs that cover most of the human body and are commonly known as peach fuzz. Attached to those hairs is a distinct population of touch-sensitive neurons, low-threshold mechanoreceptors carrying a specific molecular signature. The findings, with postdoctoral fellow Mahar Fatima as first author, were published in Neuron and supported in part by the National Institutes of Health. To test the connection, researchers stroked the animals' vellus-like hairs with a small loop of thread, producing itch through pure mechanical stimulation. Having identified the responding neurons, they engineered them to be activated by blue light. Shining light on a mouse's skin produced the same scratching that the thread had, which is about as clean a causal demonstration as sensory neuroscience offers. The team also identified proteins that carry the signal from hair to the spinal cord. Human neurons grown in culture responded to those same proteins. Duan said the work suggests humans "may have this same kind of mechanism to transmit mechanical itch." Two Kinds of Itch, One of Which Medicine Handles Badly The distinction that makes this matter clinically is between chemical and mechanical itch. Chemical itch is the familiar kind. A mosquito bite, poison ivy, an allergic reaction. Histamine and related molecules activate their receptors on sensory neurons, and antihistamines and topical treatments provide at least partial relief. Mechanical itch is different. It is triggered by light touch rather than by a chemical mediator, and it travels along a separate neural pathway. It is also the itch that dominates in chronic inflammatory skin disease. Duan has said itch is a major symptom in most patients with chronic skin inflammation, and that treatments effective against chemical itch do not work against inflammation-driven itch. That gap is why a dedicated mechanical circuit is interesting. When the team studied mice with chronic skin inflammation, the rodent analog of eczema, animals with the neurons intact scratched as expected. Where those neurons were genetically removed or silenced, mechanical itch was eliminated under both normal and inflammatory conditions. Why Humans Are Not Scratching Constantly An obvious objection arises. Human bodies are covered in vellus hair, with a few exceptions such as the palms. If those hairs are wired to itch-transmitting neurons, why is ordinary life not unbearable? The answer comes from earlier work by the same group, described by the University of Michigan. Within the spinal cord, gating circuits block low-level mechanical itch signals unless they are activated in a particular pattern. In 2019, Duan's team mapped part of that circuitry from skin to spinal cord, publishing in Neuron the identification of a spinal circuit for mechanical itch and showing that one neuron type is selectively required to transmit mechanical but not chemical itch. Inhibitory interneurons normally act as gatekeepers, and when that gating breaks down, patients experience chronic itch. The new study fills in the peripheral end of the same pathway. There is also a plausible evolutionary logic. Duan notes that peach fuzz and peach fuzz-like hairs grow in greater numbers near the mouths and ears of both humans and mice, suggesting they may function as a perimeter alarm, alerting mammals when a pest or parasite approaches an opening in the body. Chronic itch, on that reading, is a warning system that will not stand down. The Distance Between a Mouse and a Prescription The limitations here are the standard ones for basic neuroscience, and they are substantial. Every key experiment was performed in mice. Vellus-like hairs in mice resemble human vellus hairs but are not identical, and the neuronal population has not been confirmed in human skin. The cultured human neurons that responded to the relevant proteins are suggestive, not proof. Optogenetic silencing in laboratory animals is a research technique, not a therapy, and no drug currently targets this pathway in humans. Chronic itch, defined as itching lasting six weeks or longer, accompanies eczema, diabetic neuropathy, multiple sclerosis, and some cancers, and effective treatments are scarce. That unmet need is real, and it is also why early-stage findings in this field tend to be oversold. Nothing in this work changes treatment for anyone today, and people with persistent itch should be evaluated by a dermatologist or physician, since itch can signal underlying systemic disease. What the study does provide is a specific, anatomically defined circuit rather than a diffuse hypothesis. According to the release distributed through EurekAlert, the discovery opens new avenues for understanding conditions characterized by persistent itchiness. In a field where most chronic itch patients are still given antihistamines that work via a different mechanism entirely, identifying the right target is not a small step. Key Questions Answered What did researchers discover? A previously unrecognized class of fine, vellus-like hairs in mice and a dedicated population of touch-sensitive neurons connected to them that transmit mechanical itch. How is mechanical itch different from a mosquito bite? A mosquito bite produces a chemical itch driven by histamine and related molecules. Mechanical itch is triggered by light touch and travels along a separate pathway that antihistamines do not address. Was this tested in humans? Not directly. All key experiments were conducted in mice, though human neurons grown in culture responded to the same signaling proteins. The hair-neuron pairing has not been confirmed in human skin. Why does this matter for eczema? In mice with chronic skin inflammation, removing or silencing these neurons eliminated mechanical itch, suggesting the pathway contributes to the itch that dominates inflammatory skin disease. Why don't we itch all the time? Gating circuits in the spinal cord block low-level mechanical itch signals unless they are activated in a specific pattern. Does this lead to a new drug? Not yet. It identifies a potential target. Developing and testing a therapy in humans would take years and could fail. When should someone see a doctor about itching? Itching that persists for six weeks or more, or that occurs without a visible rash, warrants medical evaluation because it may indicate an underlying condition. Published by Medicaldaily.com